Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Enterovirus D, Human | 4 | 2019 | 96 | 1.03 | Why? |
| Enterovirus Infections | 4 | 2019 | 404 | 0.87 | Why? |
| Respiratory Tract Infections | 9 | 2019 | 6817 | 0.82 | Why? |
| Gastroenteritis | 2 | 2017 | 489 | 0.56 | Why? |
| Influenza B virus | 2 | 2017 | 815 | 0.55 | Why? |
| DNA | 1 | 2018 | 778 | 0.48 | Why? |
| Virus Diseases | 4 | 2018 | 3779 | 0.48 | Why? |
| Parechovirus | 1 | 2012 | 48 | 0.47 | Why? |
| Viruses | 4 | 2018 | 2238 | 0.46 | Why? |
| Phylogeny | 9 | 2021 | 13341 | 0.41 | Why? |
| Influenza, Human | 7 | 2021 | 10779 | 0.39 | Why? |
| Viral Load | 6 | 2020 | 15850 | 0.36 | Why? |
| Influenza A Virus, H1N1 Subtype | 3 | 2017 | 2984 | 0.36 | Why? |
| Intensive Care Units | 5 | 2020 | 29594 | 0.34 | Why? |
| Influenza A virus | 1 | 2019 | 2234 | 0.33 | Why? |
| Respiratory System | 2 | 2017 | 3213 | 0.32 | Why? |
| Picornaviridae Infections | 1 | 2012 | 544 | 0.32 | Why? |
| Molecular Diagnostic Techniques | 3 | 2017 | 4239 | 0.31 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 3633 | 0.31 | Why? |
| Herpesvirus 4, Human | 2 | 2020 | 387 | 0.31 | Why? |
| Diarrhea | 1 | 2017 | 2743 | 0.28 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.27 | Why? |
| Bacterial Infections | 2 | 2017 | 2229 | 0.27 | Why? |
| Sequence Analysis, DNA | 7 | 2019 | 2830 | 0.27 | Why? |
| Patient Admission | 1 | 2019 | 5250 | 0.23 | Why? |
| Nasopharynx | 2 | 2018 | 10224 | 0.23 | Why? |
| Capsid Proteins | 3 | 2019 | 365 | 0.21 | Why? |
| Specimen Handling | 1 | 2018 | 6190 | 0.21 | Why? |
| Mediastinal Neoplasms | 1 | 2021 | 57 | 0.20 | Why? |
| Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 106 | 0.20 | Why? |
| Infant | 9 | 2021 | 30274 | 0.19 | Why? |
| Italy | 14 | 2021 | 38444 | 0.19 | Why? |
| Antibodies, Bispecific | 1 | 2021 | 207 | 0.19 | Why? |
| Glucosyltransferases | 1 | 2018 | 29 | 0.19 | Why? |
| Child, Preschool | 10 | 2021 | 36283 | 0.19 | Why? |
| RNA, Viral | 5 | 2020 | 32276 | 0.18 | Why? |
| Campylobacter | 1 | 2017 | 34 | 0.17 | Why? |
| Real-Time Polymerase Chain Reaction | 5 | 2020 | 11367 | 0.17 | Why? |
| Echinocandins | 1 | 2018 | 139 | 0.17 | Why? |
| Fungal Proteins | 1 | 2018 | 133 | 0.17 | Why? |
| Measles virus | 1 | 2018 | 194 | 0.16 | Why? |
| Blood | 1 | 2018 | 274 | 0.16 | Why? |
| Molecular Sequence Data | 4 | 2019 | 3198 | 0.16 | Why? |
| Epstein-Barr Virus Infections | 1 | 2020 | 366 | 0.16 | Why? |
| Central Nervous System Infections | 1 | 2018 | 158 | 0.15 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2018 | 265 | 0.15 | Why? |
| Child | 10 | 2021 | 70012 | 0.15 | Why? |
| Immunocompetence | 1 | 2017 | 280 | 0.15 | Why? |
| Critical Care | 1 | 2019 | 14081 | 0.15 | Why? |
| Seasons | 2 | 2019 | 4071 | 0.15 | Why? |
| Plasma | 2 | 2018 | 1809 | 0.14 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 511 | 0.14 | Why? |
| Human bocavirus | 1 | 2015 | 142 | 0.14 | Why? |
| Sequence Homology, Amino Acid | 1 | 2017 | 945 | 0.14 | Why? |
| Nose | 1 | 2020 | 1093 | 0.13 | Why? |
| Enterovirus | 1 | 2018 | 402 | 0.13 | Why? |
| Rotavirus | 1 | 2017 | 329 | 0.13 | Why? |
| Candidemia | 1 | 2018 | 353 | 0.13 | Why? |
| Candida | 1 | 2018 | 425 | 0.13 | Why? |
| Fomites | 1 | 2020 | 709 | 0.13 | Why? |
| Parvoviridae Infections | 1 | 2015 | 222 | 0.13 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.13 | Why? |
| Kinetics | 2 | 2018 | 3238 | 0.12 | Why? |
| Cytomegalovirus | 1 | 2018 | 600 | 0.12 | Why? |
| Genotype | 5 | 2018 | 4697 | 0.12 | Why? |
| Molecular Epidemiology | 1 | 2018 | 1638 | 0.12 | Why? |
| Adolescent | 9 | 2021 | 86841 | 0.11 | Why? |
| History, 21st Century | 1 | 2019 | 1849 | 0.11 | Why? |
| Pneumococcal Infections | 1 | 2018 | 562 | 0.11 | Why? |
| DNA, Viral | 2 | 2020 | 2521 | 0.11 | Why? |
| Cluster Analysis | 3 | 2018 | 3001 | 0.11 | Why? |
| Measles | 1 | 2018 | 608 | 0.11 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.11 | Why? |
| Infant, Newborn | 6 | 2021 | 23105 | 0.11 | Why? |
| Cerebrospinal Fluid | 1 | 2012 | 234 | 0.10 | Why? |
| Communicable Diseases, Imported | 1 | 2018 | 843 | 0.10 | Why? |
| Mothers | 1 | 2021 | 1624 | 0.10 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2017 | 846 | 0.10 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.10 | Why? |
| Hospitalization | 3 | 2017 | 54280 | 0.10 | Why? |
| Orthomyxoviridae Infections | 1 | 2017 | 1001 | 0.10 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
| Sentinel Surveillance | 1 | 2017 | 1093 | 0.10 | Why? |
| Mutation | 3 | 2018 | 12376 | 0.10 | Why? |
| Base Sequence | 1 | 2017 | 3581 | 0.09 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2017 | 1439 | 0.09 | Why? |
| Humans | 34 | 2021 | 930598 | 0.09 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.09 | Why? |
| Adult | 15 | 2021 | 244371 | 0.09 | Why? |
| Sensitivity and Specificity | 3 | 2020 | 22971 | 0.09 | Why? |
| Genomics | 1 | 2021 | 3118 | 0.09 | Why? |
| Male | 18 | 2021 | 367725 | 0.09 | Why? |
| Genes, Viral | 1 | 2014 | 1428 | 0.09 | Why? |
| Female | 18 | 2021 | 380317 | 0.09 | Why? |
| Hepatitis C, Chronic | 1 | 2017 | 973 | 0.09 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.09 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.09 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2021 | 3607 | 0.08 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2021 | 5837 | 0.08 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.08 | Why? |
| Aged, 80 and over | 8 | 2021 | 88759 | 0.08 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.08 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.08 | Why? |
| Public Health Surveillance | 1 | 2019 | 3129 | 0.07 | Why? |
| Polymerase Chain Reaction | 2 | 2018 | 6740 | 0.07 | Why? |
| Feces | 3 | 2018 | 4235 | 0.07 | Why? |
| Aged | 12 | 2021 | 215776 | 0.07 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.07 | Why? |
| Fever | 1 | 2020 | 7795 | 0.06 | Why? |
| Nursing Homes | 1 | 2020 | 4155 | 0.06 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2021 | 5164 | 0.06 | Why? |
| Coronavirus | 3 | 2020 | 18339 | 0.06 | Why? |
| Longitudinal Studies | 2 | 2017 | 9893 | 0.06 | Why? |
| Coronaviridae Infections | 1 | 2007 | 442 | 0.06 | Why? |
| Viral Proteins | 2 | 2020 | 7370 | 0.06 | Why? |
| Virus Shedding | 1 | 2018 | 5834 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.06 | Why? |
| Disease Outbreaks | 3 | 2019 | 27595 | 0.06 | Why? |
| Transplant Recipients | 1 | 2018 | 4982 | 0.06 | Why? |
| Europe | 4 | 2020 | 12702 | 0.05 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2020 | 13720 | 0.05 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2021 | 325 | 0.05 | Why? |
| Genetic Variation | 1 | 2014 | 3919 | 0.05 | Why? |
| Dependovirus | 1 | 2021 | 272 | 0.05 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.05 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.05 | Why? |
| HIV-1 | 1 | 2014 | 3365 | 0.05 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.05 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 5002 | 0.04 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.04 | Why? |
| Asia, Southeastern | 1 | 2018 | 390 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.04 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| Drug Resistance, Fungal | 1 | 2018 | 191 | 0.04 | Why? |
| Microbial Viability | 1 | 2020 | 406 | 0.04 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.04 | Why? |
| Sus scrofa | 1 | 2017 | 205 | 0.04 | Why? |
| Sustained Virologic Response | 1 | 2017 | 378 | 0.04 | Why? |
| Enterovirus A, Human | 1 | 2018 | 180 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| Body Weight | 1 | 2021 | 1074 | 0.04 | Why? |
| Geography | 1 | 2021 | 1801 | 0.03 | Why? |
| Allografts | 1 | 2018 | 761 | 0.03 | Why? |
| Opportunistic Infections | 1 | 2020 | 602 | 0.03 | Why? |
| Cuba | 1 | 2014 | 202 | 0.03 | Why? |
| Lymphocyte Subsets | 1 | 2020 | 987 | 0.03 | Why? |
| Africa, Western | 1 | 2014 | 363 | 0.03 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2021 | 1267 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.03 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Hospitals | 1 | 2012 | 11793 | 0.03 | Why? |
| Pneumococcal Vaccines | 1 | 2018 | 571 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.03 | Why? |
| Mutation Rate | 1 | 2014 | 382 | 0.03 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2018 | 1706 | 0.03 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2017 | 1083 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2020 | 2093 | 0.03 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.03 | Why? |
| Mice, Inbred C57BL | 1 | 2021 | 5542 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.02 | Why? |
| Sweden | 1 | 2017 | 1969 | 0.02 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.02 | Why? |
| HIV Infections | 1 | 2014 | 11620 | 0.02 | Why? |
| Hepacivirus | 1 | 2017 | 1509 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Swine Diseases | 1 | 2017 | 1219 | 0.02 | Why? |
| Animals | 3 | 2021 | 78931 | 0.02 | Why? |
| Emigrants and Immigrants | 1 | 2014 | 888 | 0.02 | Why? |
| Antiviral Agents | 1 | 2017 | 41703 | 0.02 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 2426 | 0.02 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2021 | 10998 | 0.02 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Influenza Vaccines | 1 | 2018 | 2941 | 0.01 | Why? |
| Societies, Medical | 1 | 2018 | 6907 | 0.01 | Why? |
| Mice | 1 | 2021 | 21357 | 0.01 | Why? |
| Evolution, Molecular | 1 | 2014 | 3691 | 0.01 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.01 | Why? |
| Incidence | 2 | 2015 | 25622 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Virus Replication | 1 | 2018 | 14331 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Infection Control | 1 | 2018 | 23131 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |